Select Location & Language

grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

July 19, 2018

Omnicell to Release Second Quarter 2018 Earnings Results on July 26, 2018

Download PDF

MOUNTAIN VIEW, Calif., July 19, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, July 26, 2018 to discuss the Company's Second Quarter 2018 financial results.

What:

Omnicell Second Quarter 2018 earnings conference call and webcast

When:

July 26, 2018, 1:30 p.m. PT

Who:

Randall Lipps, chairman, president, chief executive officer, and founder Peter Kuipers, chief financial officer

Where:

The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 7290938. The webcast can be accessed at: http://ir.omnicell.com/events.cfm.

How:

Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.

Replay:

Available starting at 4:30 p.m. PT on July 26, 2018, through 11:59 p.m. PT on September 6, 2018. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 7290938.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,500 facilities worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-E

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/omnicell-to-release-second-quarter-2018-earnings-results-on-july-26-2018-300683790.html

SOURCE Omnicell, Inc.

Peter Kuipers, Chief Financial Officer, 800-850-6664, peter.kuipers@omnicell.com